

Management of psoriatic arthritis has advanced substantially in recent years, with emerging targeted therapies and disease-specific studies redefining patient outcomes. The high burden of comorbidities associated with the disease—the theme of World Psoriasis day 2025—alongside limited understanding of disease pathogenesis, highlights the continued need for optimised care and innovative therapies.
Rheumatology
|31st Dec, 2025
|Journal of the American Medical Association
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet
Rheumatology
|15th Jan, 2026
|The Lancet